| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| R&D Expense | $80.3M | +14.4% |
| SG&A Expense | $30.6M | +15.7% |
| Operating Income | -$110.9M | -14.8% |
| Pre-tax Income | -$92.9M | -12.8% |
| Income Tax | $0 | — |
| Net Income | -$92.9M | -12.8% |
| EPS (Basic) | -$3.33 | +0.9% |
| EPS (Diluted) | -$3.33 | +0.9% |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.2M | +83.0% |
| Current Assets | $172.3M | -11.0% |
| Total Assets | $183.2M | -10.1% |
| Current Liabilities | $15.0M | +29.9% |
| Stockholders' Equity | $161.0M | -13.0% |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$75.3M | +3.7% |
| Capital Expenditures | $1.2M | +28.5% |
| Investing Cash Flow | $41.4M | -28.4% |
| Financing Cash Flow | $58.1M | +3575.9% |
| Free Cash Flow | -$76.5M | +3.3% |